Wednesday, December 3, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tesla’s Lofty Valuation Faces Scrutiny from Famed Short Seller

Felix Baarz by Felix Baarz
December 2, 2025
in Analysis, Automotive & E-Mobility, Market Commentary, Nasdaq
0
Tesla Stock
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Michael Burry, the investor who gained fame for his prescient bet against the U.S. housing market in 2008, has turned his analytical focus to Tesla. His assessment is stark, labeling the electric vehicle pioneer as “ridiculously overvalued” with a market capitalization of $1.4 trillion. He further contends that shareholders are being systematically diluted by the company’s compensation practices. This critique raises a pivotal question for the market: can Elon Musk’s vision continue to justify the premium, or are the bears poised to be proven correct?

A Shifting Narrative and Stalling Growth

Burry’s analysis, detailed in a recent Substack newsletter, takes direct aim at the evolving story around Tesla. He observes a pattern where the company’s dominant narrative shifts as competition intensifies. Initially, the focus was entirely on electric vehicles until rivals emerged. The emphasis then moved to autonomous driving technology, again until competitors entered the space. Now, Burry notes, the narrative is centered on robotics and the Optimus humanoid robot, anticipating the same competitive dynamic.

This shift in focus coincides with a notable deceleration in Tesla’s core business. Vehicle delivery growth stalled in 2024 and reversed into a decline for 2025, prompting increased attention on future projects like the Cybercab robotaxi.

The Dilution Dilemma and Soaring Valuation

A core component of Burry’s critique is shareholder dilution. He calculates that Tesla dilutes existing shareholders by approximately 3.6% annually through stock-based compensation, with no share buybacks to provide an offset. For context, Amazon’s annual dilution rate is about 1.3%, while even Palantir—a company known for high stock compensation—comes in at 4.6%, only slightly above Tesla’s rate.

Burry explicitly links this trend to Elon Musk’s recently approved compensation package, valued at a trillion dollars, warning that “the dilution will certainly continue.”

The valuation metrics supporting his bearish stance are striking. Tesla currently trades at a price-to-earnings (P/E) ratio of roughly 295. Meanwhile, the company’s earnings are declining for the second consecutive year. For most high-growth tech firms, a P/E over 50 is considered aggressive. Based on current figures, Tesla’s stock would need to fall by around 80%, or its earnings would have to increase sixfold, to reach a P/E of 50.

Should investors sell immediately? Or is it worth buying Tesla?

Regional Challenges and Technical Concerns

The competitive and operational pressures are particularly acute in specific markets. In Europe, Tesla’s challenges are mounting. October deliveries plummeted by 48.5% year-over-year, even as the overall European EV market expanded by 26%. For the full year, Tesla’s European sales are tracking for a decline of approximately 30%. Volkswagen has already overtaken Tesla in the region, selling three times as many vehicles through September.

Further complicating the landscape, new data indicates that European customer willingness to purchase Chinese electric vehicles has increased by 16% over the past twelve months, presenting an additional hurdle for the U.S. automaker.

Adding a technical dimension to the concerns, a European EV repair specialist, Croatia-based EV Clinic, has warned of “catastrophic” failure rates for specific LG batteries used in Model 3 and Model Y vehicles. While Panasonic batteries are estimated to last about 250,000 miles, the Chinese-made LG NCM811 packs are reportedly failing at around 150,000 miles, with cell-level repairs deemed impossible in over 90% of cases.

Divergent Views on Wall Street

Despite Burry’s comprehensive critique, Wall Street analysts remain divided. Mizuho Securities reduced its price target on Tesla from $485 to $475 but maintained its “Outperform” rating. Melius Research goes further, labeling Tesla a “Must Own” stock. Their thesis argues that in the multi-trillion dollar autonomous driving sector, “hundreds of billions of value” will ultimately flow to Tesla.

The fundamental debate for investors is now framed in stark terms: Will the promise of Musk’s long-term vision for robotics and autonomy ultimately eclipse the present-day realities of valuation, dilution, and competitive pressure, or has the legendary short-seller identified another major market mispricing?

Ad

Tesla Stock: Buy or Sell?! New Tesla Analysis from December 3 delivers the answer:

The latest Tesla figures speak for themselves: Urgent action needed for Tesla investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 3.

Tesla: Buy or sell? Read more here...

Tags: Tesla
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Ocugen Stock
Analysis

Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?

December 3, 2025
PayPal Stock
Analysis

PayPal’s Dividend Debut Fails to Rally Investor Confidence

December 3, 2025
Marvell Technology Stock
AI & Quantum Computing

Marvell Technology’s Strategic Surge: A Dual-Pronged Bet on AI Dominance

December 3, 2025
Next Post
Micron Stock

Micron's Strategic Bet: A Multi-Billion Dollar Push to Dominate AI Memory

Rubrik Stock

Can Rubrik's AI Security Focus Unlock Shareholder Value?

Barrick Mining Stock

Barrick Gold's Strategic Unlocking Plan Ignites Share Rally

Recommended

Rocket Lab USA Stock

Rocket Lab USA: A Study in Contrasting Financial Signals

3 months ago
Deere Stock

Deere’s Market Crossroads: Divergent Signals from Analysts and Investors

2 months ago
Amgen Stock

Amgen’s Strategic Crossroads: Innovation Meets Intensifying Competition

3 months ago
Eastman Chemical Stock

Eastman Chemical Leadership Bets Big with Major Stock Purchases

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Beyond Meat Shares: A Speculative Spike Meets Harsh Financial Reality

Eli Lilly’s Strategic Gambit: A Price War for Market Supremacy

Amazon’s Dual-Pronged Strategy to Reignite Growth

Alphabet’s Stock Surge: AI Ambitions Fuel Record Rally

Leadership Shake-Up at Red Cat Amid Financial Shortfall

Tesla’s Valuation Under Scrutiny Amid Conflicting Signals

Trending

Ocugen Stock
Analysis

Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?

by Felix Baarz
December 3, 2025
0

Investors in Ocugen are facing a critical test of resolve. The biotech firm's shares have been under...

PayPal Stock

PayPal’s Dividend Debut Fails to Rally Investor Confidence

December 3, 2025
Marvell Technology Stock

Marvell Technology’s Strategic Surge: A Dual-Pronged Bet on AI Dominance

December 3, 2025
Beyond Meat Stock

Beyond Meat Shares: A Speculative Spike Meets Harsh Financial Reality

December 3, 2025
Eli Lilly Stock

Eli Lilly’s Strategic Gambit: A Price War for Market Supremacy

December 3, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen’s Pivotal Moment: Can a Florida Presentation Reverse Its Fortunes?
  • PayPal’s Dividend Debut Fails to Rally Investor Confidence
  • Marvell Technology’s Strategic Surge: A Dual-Pronged Bet on AI Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com